Calcium-activated proteolysis as a therapeutic target in cerebrovascular disease

Annals of the New York Academy of Sciences

Volumn 825, Issue , 1997, Pages 95-103

  Lee, Kevin S ^a,b   Yanamoto, Hiroji ^a   Fergus, Andrea ^a   Hong, Seung Chyul ^a   Kang, Sung Don ^a   Cappelletto, Barbara ^a   Toyoda, Tomikatsu ^a   Kassell, Neal F ^a   Bavbek, Murad ^a   Kwan, Aij Lie ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALPAIN; CYTOSKELETON PROTEIN; LEUPEPTIN; PROTEINASE INHIBITOR;

BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; BRAIN PERFUSION; BRAIN VASOSPASM; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; NEUROPROTECTION; NONHUMAN; PROTEIN DEGRADATION; SUBARACHNOID HEMORRHAGE;

EID: 9844225599     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48419.x     Document Type: Conference Paper

References (64)

1. SIESJÖ, B. K. 1992. Pathophysiology and treatment of focal cerebral ischemia, Part 1: Pathophysiology. J. Neurosurg. 77: 169-184.
2. SIESJÖ, B. K. 1992. Pathophysiology and treatment of focal cerebral ischemia, Part 2: Mechanisms of damage and treatment. J. Neurosurg. 77: 337-354.
3. SUZUKI, K., S. TSUJI, S. KUBOTA, Y. KIMURA & K. IMAHORI. 1981. Limited autolysis of calcium-activated neural protease (CANP) changes its sensitivity to calcium ions. J. Biochem. 90: 275-278.
4. SAIDO, T., H. SORIMACHI & K. SUZUKI. 1994. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8: 814-822.
5. SEUBERT, P., K. LEE & G. LYNCH. 1989. Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 492: 366-370.
6. SAIDO, T., M. YOKOTA, S. NAGAO, I. YAMAURA, E. TANI, T. TSUCHIYA, K. SUZUKI & S. KAWASHIMA. 1993. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268: 25239-25243.
7. ROBERTS-LEWIS, J., M. SAVAGE, V. MARCY, L. PINSKER & R. SIMAN. 1994. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14: 3934-3944.
8. HONG, S.-C., Y. GOTO, G. LANZINO, S. SOLEAU, N. F. KASSELL & K. S. LEE. 1994. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25: 663-669.
9. HONG, S.-C., G. LANZINO, Y. GOTO, S. KANG, F. SCHOTTLER, N. F. KASSELL & K. S. LEE. 1994. Calcium-activated proteolysis in rat neocortex induced by transient focal ischemia. Brain Res. 661: 43-50.
10. TAFT, W., K. TENNES-REES, R. BLAIR, G. CLIFTON & R. DELORENZO. 1988. Cerebral ischemia decreases endogenous calcium-dependent protein phosphorylation in gerbil brain. Brain Res. 447: 159-163.
11. CHURN, S. B., W. C. TAFT & R. J. DELORENZO. 1990. Effects of ischemia on multifunctional calcium/calmodulin-dependent protein kinase type II in the gerbil. Stroke 21 (Suppl. II): 112-116.
12. CHURN, S., A. YAGHMAI, J. POVLISHOCK, A. RAFIQ & R. J. DELORENZO. 1992. Global forebrain ischemia results in decreased immunoreactivity of calcium/calmodulin-dependent protein kinase II. J. Cereb. Blood Flow Metab. 12: 784-793.
13. MORIOKA, M., K. FUKUNAGA, S. YASUGAWA, S. NAGAHIRO, Y. USHIOI & E. MIYAMOTO. 1992. Regional and temporal alterations in calcium/calmodulin-dependent protein kinase and calcineurin in the hippocampus of rat brain after transient forebrain ischemia. J. Neurochem. 58: 1798-1809.
14. YAMAMOTO, H., K. FUKUNAGA, K. S. LEE, T. R. SODERLING. 1992. Ischemia-induced loss of brain calcium/calmodulin-dependent protein kinase II. J. Neurochem. 58: 1110-1117.
15. YAMASAKI, Y., H. ONODERA, K. ADACHI, H. SHOZUHARA & K. KOGURE. 1992. Alteration in the immunoreactivity of the calcineurin subunits after ischemic hippocampal damage. Neurosci. 49: 545-556.
16. KUWAKI, T., H. SATOH, T. ONO, F. SHIBAYAMA, T. YAMASHITA & T. NISHIMURA. 1989. Nilvadipine attenuates ischemic degradation of gerbil brain cytoskeletal proteins. Stroke 20: 78-83.
17. HATAKEYAMA, T., M. MATSUMOTO, J. M. BRENGMAN & T. YANAGIHARA. 1988. Immunohistochemical investigation of ischemia and postischemic damage after bilateral carotid occlusion in gerbils. Stroke 19: 1526-1534.
18. INUZUKA, T., A. TAMURA, S. SATO, T. KIRINO, K. YANAGISAWA, I. TOYOSHIMA & T. MIYATAKE. 1990. Changes in the concentrations of cerebral proteins following occlusion of the middle cerebral artery in rats. Stroke 21: 917-922.
19. KAKU, Y., Y. YONEKAWA, T. TSUKAHARA, N. OGATA, T. KIMURA & T. TANIGUCHI. 1993. Alterations of a 200kDa neurofilament in the rat hippocampus after forebrain ischemia. J. Cereb. Blood Flow Metab. 13: 402-408.
20. KITAKAWA, L., M. MATSUMOTO, M. NIIOBE, K. MIKOSHIBA, R. HARA, H. UEDA, N. HANDA, R. FUKUNAKA, Y. ISAKA, K. KIMURA & T. KAMADA. 1989. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage - immunohistochemical investigation of dendritic damage. Neurosci. 31: 401-411.
21. LEE, K. S., S. FRANK, P. VANDERKLISH, A. ARAI & G. LYNCH. 1991. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA 88: 7233-7237.
22. MATSUMOTO, M., K. YAMAMOTO, H. A. HOMBURGER & T. YANAGIHARA. 1987. Early detection of cerebral ischemic damage and repair process in the gerbil by use of an immunohistochemical technique. Mayo Clin. Proc. 62: 460-472.
23. NAKAMURA, M., M. ARAKI, K. OGURO & T. MASUZAWA. 1992. Differential distribution of 68 kD and 200 kD neurofilament proteins in the gerbil hippocampus and their early distributional changes following transient forebrain ischemia. Brain Res. 89: 31-39.
24. OGATA, N., Y. YONEKAWA, W. TAKI, R. KANNAGI, T. MURACHI, T. HAMAKUBO & H. KIKUCHI. 1989. Degradation of neurofilament protein in cerebral ischemia. J. Neurosurg. 70: 103-107.
25. TOMIOKA, C., K. NISHIOKA & K. KOGURE. 1992. Absence of early destructive changes of cytoskeletal proteins after transient ischemia in the rat. Brain Res. 586: 352-357.
26. YANAGIHARA, T., T. YOSHIMINE, K. MORIMOTO, L. YAMAMOTO & H. A. HOMBURGER. 1985. Immunohistochemical investigation of cerebral ischemia in gerbils. J. Neuropathol. Exp. Neurol. 44: 204-215.
27. YOSHIMI, K., M. TAKEDA, T. NISHIMURA, T. KUDO, Y. NAKAMURA, K. TADA & N. IWATA. 1991. An immunohistochemical study of MAP2 and clathrin in gerbil hippocampus after cerebral ischemia. Brain Res. 560: 149-158.
28. YOSHIMINE, T., K. MORIMOTO, J. M. BRENGMAN, H. A. HOMBURGER, H. MOGAMI & T. YANAGIHARA. 1985. Immunohistochemical investigation of cerebral ischemia during recirculation. J. Neurosurg. 63: 922-928.
29. LEE, K. S. 1996. The role of calcium-activated proteolysis in ischemic brain injury. In Novel Therapies for CNS Injuries: Rationales and Results. P. L. Peterson & J. W. Phillis, Eds. 347-361. CRC Press. Boca Raton, FL.
30. YAMAMOTO, H., T. TOYODA, B. BAHR, G. LYNCH, N. KASSELL & K. LEE. Spatial and temporal features of spectrin proteolysis after focal cerebral ischemia: the effects of temporary versus permanent ischemia. Submitted.
31. NEUMAR, R., S. HAGLE, D. DEGRACIA, G. KRAUSE & B. WHITE. 1996. Brain m-calpain autolysis during global cerebral ischemia. J. Neurochem. 66: 421-424.
32. INOMATA, M., Y. KASAI, M. NAKAMURA & S. KAWASHIMA. 1988. Activation mechanism of calcium-activated neutral protease. J. Biol. Chem. 263: 19783-19787.
33. SIMAN, R. & J. NOSZEK. 1988. Excitatory amino acids activate calpain I and introduce structural protein breakdown in vivo. Neuron 1: 279-287.
34. SIMAN, R., J. NOSZEK & C. KEGERISE. 1989. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9: 1579-1590.
35. SEUBERT, P., G. IVY, J. LARSON, J. LEE, K. SHAHI, M. BAUDRY & G. LYNCH. 1988. Entorhinal cortex lesion produces a calpain-mediated degradation of brain spectrin in dentate gyrus. 1. Biochemical studies. Brain Res. 459: 226-232.
36. SEUBERT, P., J. LARSON, M. OLIVER, M. JUNG, M. BAUDRY & G. LYNCH. 1988. Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampus. Brain Res. 460: 189-194.
37. CANER, H., J. COLLINS, S. HARRIS, N. F. KASSELL & K. S. LEE. 1993. Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res. 607: 354-356.
38. SAITO, K., J. ELCE, J. HAMOS & R. NIXON. 1993. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer's disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA 90: 2628-2632.
39. SAATMAN, K., H. MURAI, R. BARTUS, D. SMITH, N. HAYWARD, B. PERRI & T. MCINTOSH. 1996. Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in rat. Proc. Natl. Acad. Sci. USA 93: 3428-3433.
40. RAMI, A. & J. KRIEGLSTEIN. 1993. Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609: 67-70.
41. BARTUS, R., K. BAKER, A. HEISER, S. SAWYER, R. DEAN, P. ELLIOTT & J. STRAUB. 1994. Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J. Cereb. Blood Flow Metab. 14: 537-544.
42. BARTUS, R., N. HAYWARD, P. ELLIOTT, S. SAWYER, K. BAKER, R. DEAN, A. AKIYAMA, J. STRAUB, S. HARBESON, Z. LI & J. POWERES. 1994. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Stroke 25: 2265-2270.
43. HOSSMAN, K.-A., H. LECHTAPE-GRUTER & V. HOSSMAN. 1973. The role of cerebral blood flow for the recovery of the brain after prolonged ischemia. Z. Neurol. 204: 281-299.
44. HOSSMAN, K.-A. 1990. Hemodynamics of postischemic reperfusion of the brain. In Protection of the Brain from Ischemia. P. Weinstein & A. Faden, Eds. 21-36. Williams and Wilkins, Baltimore, MD.
45. SCHMIDT-KASTNER, R., K.-A. HOSSMAN & B. GROSSE-OPHOFF. 1987. Pial artery pressure after one hour of global ischemia. J. Cereb. Blood Flow Metab. 7: 109-117.
46. SAGHER, O., Y. JIN, Q.-A. THAI, A. FERGUS, N. F. KASSELL & K. S. LEE. 1994. Cerebral microvascular responses to endothelins: the role of Eta receptors. Brain Res. 658: 179-184.
47. BARONE, F., M. GLOBUS, W. PRICE, R. WHITE, B. STORER, G. FEUERSTEIN, R. BUSTO & E. OHLSTEIN. 1994. Endothelin levels increase in rat focal and global ischemia. J. Cereb. Blood Flow Metab. 14: 337-342.
48. VIOSSAT, I., D. DUBERGER, M. CAPELAT, E. PIROTZKY, P. CHABIRER & P. BRAQUET. 1993. Elevated tissue endothelin content during focal cerebral ischemia in the rat. J. Cardiovasc. Pharmacol. 22 (Suppl. 8): S305-S309.
49. PATEL, T., S. GALBRAITH, D. GRAHAM, H. HALLAK, A. DOHERTY & J. MCCULLOCH. 1996. Endothelin (Eta) receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J. Cereb. Blood Flow Metab. 16: 950-958.
50. FERGUS, A. & K. LEE. Blockade of endothelin-induced vasoconstriction in cerebral microvessels by calpain inhibitors. Unpublished data.
51. KASSELL, N. F., T. SASAKI, A. COLOHAN & G. NAZAR. 1985. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562-572.
52. MACDONALD, R. L. & B. WEIR. 1991. A review of hemoglobin and the pathogenesis of cerebral vasospam. Stroke 22: 971-982.
53. YAMAURA, I., E. TANI, T. SAIDO, K. SUZUKI, N. MINAMI & Y. MAEDA. 1993. Calpain-calpastatin system of canine basilar artery in vasospasm. J. Neurosurg. 79: 537-543.
54. LEE, K. S., P. L. FOLEY, P. VANDERKLISH, G. LYNCH, Y. GOTO & N. F. KASSELL. 1993. The role of calcium-activated proteolysis in vasospasm after subarachnoid hemorrhage. In Cerebral Vasospasm. J. M. Findlay, Ed. 85-88. Elsevier Science Publishers. B. V., North Holland.
55. MINAMI, N., E. TANI, Y. MAEDA, I. YAMAURA & A. NAKANO. 1993. Immunoblotting of contractile and cytoskeletal proteins of canine basilar artery in vasospasm. Neurosurgery 33: 698-705.
56. MINAMI, N., E. TANI, Y. MAEDA, I. YAMAURA & M. FUKAMI. 1992. Effects of inhibitors of protein kinase C and calpain in experimental delayed cerebral vasospasm. J. Neurosurg. 76: 111-118.
57. CAPPELLETTO, B., H. CANER, F. SCHOTTLER, D. EVELETH, P. FOLEY, N. F. KASSELL & K. S. LEE. 1993. Attenuation of vasospasm and hemoglobin-induced constriction in the rabbit basilar artery by a novel protease inhibitor (abstract). Proc. Am. Assoc. Neurol. Surg. Annu. Mtg.
58. KANG, S.-D., A. ARTHUR, C. BOALS, W. YATES, N. F. KASSELL & K. S. LEE. 1993. Systemic administration of a novel calpain inhibitor attenuates subarachnoid hemorrhage induced vasospasm (abstract). Proc. Am. Assoc. Neurol. Surg. Annu. Mtg.
59. BAVBEK, M., A.-L. KWAN, T. TOYODA, N. KASSELL, B. BAHR & K. LEE. Systemic administration of the calpain inhibitor, CX295, attenuates cerebral vasospasm in a rabbit model of SAH. Submitted.
60. WANG, K. 1990. Developing selective inhibitors of calpain. Trends Pharmacol. Sci. 11: 139-142.
61. MEHDI, S. 1991. Cell-penetrating inhibitors of calpain. Trends Biochem. Sci. 164: 150-153.
62. LI, Z., G. PATIL, Z. GOLUBSKI, H. HORI, K. TEHRANI, J. FOREMAN, D. EVELETH, R. BARTUS & J. POWERS. 1993. Peptide a-ketoester, a-ketoamide and a-ketoacid inhibitors of calpains and other cysteine proteases. J. Med. Chem. 36: 3472-3480.
63. HARBESON, S., S. ABELLEIRA, A. AKIYAMA, R. BARRETT, R. CARROLL, J. STRAUB, J. TKACZ, C. WU & G. MUSSO. 1994. Stereospecific synthesis of peptidyl a-ketoamides as inhibitors of calpain. J. Med. Chem. 37: 2918-2929.
64. WANG, K., R. NATH, A. POSNER, K. RASER, M. BUROKER-KILGORE, I. HAJIMO-HAMMADREZA, A. PROBERT, F. MARCOUX, Q. YE, E. TAKANO, M. HATANAKA, M. MAKAI, H. CANER, J. COLLINS, A. FERGUS, K. LEE, E. LUNNEY, S. HAYS & P. YUEN. 1996. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable inhibitor and is neuroprotective. Proc. Natl. Acad. Sci. USA 93: 6687-6692.